Clinical application of "Ethoxysclerol" and "Bleomycin" in the management of retention cysts of the salivary glands in pediatric patients: case studies

Relevance. Retention cysts of the salivary glands are a frequent occurrence in dental practice. Traditional treatments, such as cystadenectomy and cystotomy, are commonly employed. However, these procedures are associated with postoperative complications, including recurrence, damage to adjacent structures (e.g., ducts of neighbouring salivary glands, blood vessels, and nerves), and inadvertent opening of the submandibular salivary gland capsule.Description of clinical cases. This paper presents clinical cases of four pediatric patients diagnosed with retention cysts of the salivary glands, treated at the Department of Pediatric Maxillofacial Surgery, Russian University of Medicine. All patients received treatment with "Lauromacrogol-400" ("Ethoxysclerol") and "Bleomycin." In the postoperative period, no complications or adverse effects related to the administered drugs were observed. Follow-up examinations revealed no clinical manifestations of retention cysts or ultrasonographic evidence of cysts.Conclusions. Sclerotherapy using "Ethoxysclerol" and "Bleomycin" for the treatment of retention cysts of the salivary glands presents a viable minimally invasive alternative to conventional surgical methods, potentially mitigating the risks associated with more invasive procedures.